Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/64589
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Da Silva Planeta, Cleopatra | - |
dc.contributor.author | Aizenstein, Moacyr Luiz | - |
dc.contributor.author | DeLucia, Roberto | - |
dc.date.accessioned | 2014-05-27T11:18:00Z | - |
dc.date.accessioned | 2016-10-25T18:13:30Z | - |
dc.date.available | 2014-05-27T11:18:00Z | - |
dc.date.available | 2016-10-25T18:13:30Z | - |
dc.date.issued | 1995-01-17 | - |
dc.identifier | http://dx.doi.org/10.1016/0091-3057(94)00236-C | - |
dc.identifier.citation | Pharmacology Biochemistry and Behavior, v. 50, n. 1, p. 35-40, 1995. | - |
dc.identifier.issn | 0091-3057 | - |
dc.identifier.uri | http://hdl.handle.net/11449/64589 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/64589 | - |
dc.description.abstract | Fencamfamine (FCF) is a psychostimulant classified as an indirect dopamine agonist. The conditioning place preference (CPP) paradigm was used to investigate the reinforcing properties of FCF. After initial preferences had been determined, animals were conditioned with FCF (1.75, 3.5, or 7.0 mg/kg; IP). Only at the dose of 3.5 mg/kg FCF produced a significant place preference. Pretreatment with SCH23390 (0.05 mg/kg, SC) or naloxone (1.0 mg/kg SC) 10 min before FCF (3.5 mg/kg; IP) blocked both FCF-induced hyperactivity and CPP. Pretreatment with metoclopramide (10.0 mg/kg; IP) or pimozide (1.0 mg/kg, IP), respectively, 30 min or 4 h before FCF (3.5 mg/kg; IP), which blocked the FCF-induced locomotor activity, failed to influence place conditioning produced by FCF. In conclusion, the present study suggests that dopamine D 1 and opioid receptors are related to FCF reinforcing effect, while dopamine D 2 subtype receptor was ineffective in modifying FCF-induced CPP. | en |
dc.format.extent | 35-40 | - |
dc.language.iso | eng | - |
dc.source | Scopus | - |
dc.subject | Dopamine receptors | - |
dc.subject | Fencamfamine | - |
dc.subject | Opioid receptors | - |
dc.subject | Place conditioning | - |
dc.subject | Reinforcement | - |
dc.subject | 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate | - |
dc.subject | dopamine 1 receptor | - |
dc.subject | dopamine 2 receptor | - |
dc.subject | dopamine receptor | - |
dc.subject | dopamine receptor stimulating agent | - |
dc.subject | fencamfamin | - |
dc.subject | metoclopramide | - |
dc.subject | naloxone | - |
dc.subject | opiate receptor | - |
dc.subject | pimozide | - |
dc.subject | psychostimulant agent | - |
dc.subject | receptor subtype | - |
dc.subject | animal experiment | - |
dc.subject | conditioning | - |
dc.subject | controlled study | - |
dc.subject | drug antagonism | - |
dc.subject | hyperactivity | - |
dc.subject | intraperitoneal drug administration | - |
dc.subject | nonhuman | - |
dc.subject | place preference | - |
dc.subject | priority journal | - |
dc.subject | rat | - |
dc.subject | reinforcement | - |
dc.subject | subcutaneous drug administration | - |
dc.subject | Animal | - |
dc.subject | Binding, Competitive | - |
dc.subject | Central Nervous System Stimulants | - |
dc.subject | Conditioning, Operant | - |
dc.subject | Metoclopramide | - |
dc.subject | Naloxone | - |
dc.subject | Norbornanes | - |
dc.subject | Pimozide | - |
dc.subject | Rats | - |
dc.subject | Receptors, Dopamine D1 | - |
dc.subject | Receptors, Dopamine D2 | - |
dc.subject | Receptors, Opioid, mu | - |
dc.subject | Reinforcement (Psychology) | - |
dc.subject | Sch-23390 | - |
dc.subject | Animalia | - |
dc.title | Reinforcing properties of fencamfamine: Involvement of dopamine and opioid receptors | en |
dc.type | outro | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.contributor.institution | Universidade de São Paulo (USP) | - |
dc.description.affiliation | Departamento de Principios Ativos Naturais e Toxicologia Faculdade de Ciências Farmacêuticas UNESP, Rodovia Araraquara-Jau Km 01, CP502, CEP14801-902, Araraquara, SP | - |
dc.description.affiliation | Departamento de Farmacologia Instituto de Ciências Biomédicas USP, Şao Paulo, CEP05508-900 | - |
dc.description.affiliationUnesp | Departamento de Principios Ativos Naturais e Toxicologia Faculdade de Ciências Farmacêuticas UNESP, Rodovia Araraquara-Jau Km 01, CP502, CEP14801-902, Araraquara, SP | - |
dc.identifier.doi | 10.1016/0091-3057(94)00236-C | - |
dc.identifier.wos | WOS:A1995QA54700006 | - |
dc.rights.accessRights | Acesso restrito | - |
dc.relation.ispartof | Pharmacology Biochemistry and Behavior | - |
dc.identifier.scopus | 2-s2.0-0028799567 | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.